Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04194554
Title A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer (ASCLEPIuS)
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Michigan Rogel Cancer Center
Indications

prostate adenocarcinoma

Therapies

Abiraterone + Leuprolide + Niraparib + Prednisone

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.